Tokyo, Sept. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059015) titled 'Clinical management algorithm for embolic stroke of undetermined source' on Sept. 6.
Study Type:
Observational
Primary Sponsor:
Institute - The University of Osaka Graduate School of Medicine
Condition:
Condition - Embolic stroke of undetermined source (ESUS)
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the recurrence rate and treatment responsiveness in patients with embolic stroke of undetermined source (ESUS) based on their clinical background and risk factors. In addition, the safety of percutaneous patent foramen ovale (PFO) closure will be evaluated in patients with PFO.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1. Patients who experienced an ischemic stroke between January 2021 and April 2025 and visited or were admitted to the participating institution.
2. Patients diagnosed with embolic stroke of undetermined source.
Key exclusion criteria - Patients who did not consent to participate.
Target Size - 500
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 08 Month 05 Day
Date of IRB - 2025 Year 08 Month 08 Day
Anticipated trial start date - 2025 Year 09 Month 20 Day
Last follow-up date - 2026 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067220
Disclaimer: Curated by HT Syndication.
